AnaptysBio Inc

NAS:ANABHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$49.24+5.64%At closeAt close · Tue 20 Oct · ≈ AED 180.83 · Market cap $1.47B · Next earnings Tue 10 Nov · Extended $49.21 −0.06%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−6.7%	−55.9%	−763.2%	−671.0%	−79.5%	99.0%	—	—
Operating margin	−31.8%	−89.9%	−1,119.4%	−958.3%	−125.9%	20.4%	20.4%	+0.0 pts
Net margin	−26.6%	−91.5%	−1,251.3%	−953.7%	−159.1%	−5.6%	21.1%	+26.8 pts
EBITDA margin	−25.8%	−88.2%	−1,023.2%	−911.7%	−101.6%	29.5%	—	—
Return on equity	−5.0%	−16.2%	−49.1%	−185.7%	−204.9%	−35.6%	133.3%	+168.9 pts
Return on assets	−4.8%	−9.0%	−21.1%	−36.2%	−30.0%	−3.6%	13.6%	+17.2 pts
Return on capital employed	−6.0%	−9.1%	−19.7%	−39.6%	−26.2%	14.7%	—	—
Debt / equity	0.0×	0.1×	0.1×	0.2×	5.2×	0.4×	0.4×	+0.0%
Debt / assets	0.1%	3.3%	3.2%	3.9%	76.4%	3.9%	—	—
Interest coverage	0.0×	−39.2×	−5.5×	−9.1×	−2.3×	0.6×	—	—
Current ratio	20.0×	34.4×	17.2×	10.9×	9.5×	9.1×	9.1×	+0.0%
Quick ratio	20.0×	34.4×	17.2×	10.9×	9.5×	9.1×	—	—
Cash ratio	12.6×	30.8×	2.7×	1.0×	2.7×	6.2×	6.2×	+0.0%
Asset turnover	0.2×	0.1×	0.0×	0.0×	0.2×	0.6×	—	—
Receivables turnover	—	72.1×	7.2×	2.5×	2.2×	6.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.